Marie-Laure Pochon has resigned as executive vice president, commercial operations at Danish pharmaceutical firm Lundbeck for family and private reasons.
Pochon took over the role last September, having previously been chief executive for Lundbeck France and regional vp for France, Belgium, UK, Spain, Italy, Turkey and Germany at Lundbeck.
‘I have had a fantastic journey with Lundbeck and feel that the company now has a strong commercial platform with many product launches in the near-term future. However, for family and private reasons, I have made the decision to resign,’ Pochon said.
‘I respect Marie-Laure’s decision and would like to thank her for her dedication and contribution to Lundbeck during the five years she has been with the company,’ said Ulf Wiinberg, president and ceo of Lundbeck.
Senior vice president Ole Chrintz, who is currently responsible for Lundbeck’s international markets, will add Lundbeck’s commercial operations in Europe to his area. He is already a member of Lundbeck’s Corporate Management Group (CMG).
Lundbeck’s executive management team now consists of: Wiinberg; Anders Götzsche, executive vice president, cfo; and Anders Gersel Pedersen, executive vice president, r&d.
